{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:30:25Z","timestamp":1792301425852,"version":"4.4.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T00:00:00Z","timestamp":1422403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0110820","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T13:52:53Z","timestamp":1422453173000},"page":"e0110820","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Serum Amyloid A Is a Marker for Pulmonary Involvement in Systemic Sclerosis"],"prefix":"10.1371","volume":"10","author":[{"given":"Katja","family":"Lakota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Carns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Podlusky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katjusa","family":"Mrak-Poljsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Hinchcliff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungwha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matija","family":"Tomsic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snezna","family":"Sodin-Semrl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,1,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1186\/1755-1536-5-S1-S18","article-title":"Fibrosis in systemic sclerosis: common and unique pathobiology","volume":"5","author":"S Bhattacharyya","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"VD Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000163933","article-title":"Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes\/macrophages","volume":"63","author":"BM Kraling","year":"1995","journal-title":"Pathobiology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1164\/rccm.200705-655OC","article-title":"Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease","volume":"177","author":"C Strange","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s00296-011-1872-4","article-title":"Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease","volume":"32","author":"N Yilmaz","year":"2012","journal-title":"Rheumatol Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.37742","article-title":"Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis","volume":"65","author":"X Liu","year":"2013","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/acr.21716","article-title":"Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group","volume":"64","author":"C Muangchan","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/187221410791196632","article-title":"Serum Amyloid A and Its Potential Physiological \/ Pathological Functions\u2014an Overview of Patents","volume":"4","author":"K Lakota","year":"2010","journal-title":"Recent Patents on Endocrine, Metabolic & Immune Drug Discovery"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"C Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2492\/inflammregen.26.453","article-title":"Analysis of cytokine-driven serum amyloid A expression based on the clinical results of IL-6 blocking therapy: a new <italic>cis<\/italic>-acting mechanism of STAT3","volume":"26","author":"K Hagihara","year":"2006","journal-title":"Inflammation and regeneration"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1073\/pnas.1109382109","article-title":"Serum amyloid A opposes lipoxin A(4) to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease","volume":"109","author":"S Bozinovski","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200905-0696OC","article-title":"Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2","volume":"181","author":"ES Chen","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e5842","DOI":"10.1371\/journal.pone.0005842","article-title":"Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota","volume":"4","author":"CS Reigstad","year":"2009","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"938","DOI":"10.7150\/ijms.6152","article-title":"C-reactive protein and serum amyloid a overexpression in lung tissues of chronic obstructive pulmonary disease patients: a case-control study","volume":"10","author":"JL Lopez-Campos","year":"2013","journal-title":"Int J Med Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1615\/CritRevImmunol.v32.i4.40","article-title":"Immune functions of serum amyloid A","volume":"32","author":"KK Eklund","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1182\/blood-2005-11-011932","article-title":"Serum amyloid A is an innate immune opsonin for Gram-negative bacteria","volume":"108","author":"C Shah","year":"2006","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.atherosclerosis.2009.05.007","article-title":"Serum amyloid A induction of cytokines in monocytes\/macrophages and lymphocytes","volume":"207","author":"C Song","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref18","first-page":"535","article-title":"Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts","volume":"78","author":"K Migita","year":"1998","journal-title":"Lab Invest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e34031","DOI":"10.1371\/journal.pone.0034031","article-title":"The acute phase protein Serum Amyloid A induces lipolysis and inflammation in human adipocytes through distinct pathways","volume":"7","author":"A Faty","year":"2012","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1164\/rccm.200905-0659OC","article-title":"Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis","volume":"182","author":"TH Kim","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"H1432","DOI":"10.1152\/ajpheart.00038.2007","article-title":"Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation, and angiogenic potential in tight-skin mice","volume":"293","author":"D Weihrauch","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/cvr\/cvs089","article-title":"High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A","volume":"94","author":"M Tolle","year":"2012","journal-title":"Cardiovasc Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1371\/journal.pmed.0030287","article-title":"Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications","volume":"3","author":"RZ Yang","year":"2006","journal-title":"PLoS Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1677\/joe.1.05699","article-title":"Serum amyloid A3 expression is stimulated by dexamethasone and interleukin-6 in 3T3-L1 adipocytes","volume":"183","author":"M Fasshauer","year":"2004","journal-title":"J Endocrinol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.0300-9475.2004.01369.x","article-title":"Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines","volume":"59","author":"CF Thorn","year":"2004","journal-title":"Scand J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.4049\/jimmunol.0902941","article-title":"Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis\/SCID mouse chimera model","volume":"184","author":"M Connolly","year":"2010","journal-title":"J Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/oby.20058","article-title":"The inverse relation of HDL anti-oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects","volume":"21","author":"RP Dullaart","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/MOL.0b013e3283488c39","article-title":"Serum amyloid A in atherosclerosis","volume":"22","author":"VL King","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.24735","article-title":"Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview","volume":"61","author":"L Obici","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2353\/ajpath.2008.080201","article-title":"Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner","volume":"173","author":"PG Wilson","year":"2008","journal-title":"Am J Pathol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.066340","article-title":"Survival and causes of death in 366 Hungarian patients with systemic sclerosis","volume":"67","author":"L Czirjak","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.semarthrit.2009.06.002","article-title":"Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital","volume":"39","author":"BE Joven","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/rheumatology\/keq022","article-title":"Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis","volume":"49","author":"T Minier","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.semarthrit.2007.01.005","article-title":"Update on indices of disease activity in systemic sclerosis","volume":"37","author":"M Hudson","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/acr.21968","article-title":"C-reactive protein predictsthe long-term progression of interstitial lung disease and survival in patients with early systemic sclerosis","volume":"65","author":"X Liu","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/ard.43.4.586","article-title":"Serum amyloid A protein concentration in progressive systemic sclerosis (scleroderma)","volume":"43","author":"SR Brandwein","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"AT Masi","year":"1980","journal-title":"Arthritis & Rheumatism"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3899\/jrheum.101243","article-title":"Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population","volume":"38","author":"M Hinchcliff","year":"2011","journal-title":"J Rheumatol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/rheumatology\/kel221","article-title":"Validity of the Saint George\u2019s Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis","volume":"46","author":"L Beretta","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/acr.20591","article-title":"Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form","volume":"63","author":"M Hinchcliff","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/rheumatology\/ket223","article-title":"Sleep disturbances in systemic sclerosis: evidence for the role of gastrointestinal symptoms, pain and pruritus","volume":"52","author":"K Milette","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/prca.201100078","article-title":"Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension","volume":"6","author":"ME Yeager","year":"2012","journal-title":"Proteomics Clin Appl"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.rmed.2010.12.010","article-title":"Analysis of serum amyloid A in sarcoidosis patients","volume":"105","author":"E Bargagli","year":"2011","journal-title":"Respir Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/1721727X0700500203","article-title":"Serum amyloid a activation of inflammatory and adhesion molecules in human coronary artery and umbilical vein endothelial cells","volume":"5","author":"K Lakota","year":"2007","journal-title":"European Journal of Inflammation"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mvr.2013.07.011","article-title":"Serum amyloid A activation of human coronary artery endothelial cells exhibits a neutrophil promoting molecular profile","volume":"90","author":"K Lakota","year":"2013","journal-title":"Microvasc Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/039463200401700206","article-title":"Opposing regulation of interleukin-8 and NF-kappaB responses by lipoxin A4 and serum amyloid A via the common lipoxin A receptor","volume":"17","author":"S Sodin-Semrl","year":"2004","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref47","unstructured":"O\u2019Reilly S, Cant R, Ciechomska M, Finnegan J, Oakley F, et al. (2014) Serum Amyloid A (SAA) induces IL-6 in dermal fibroblasts via TLR2, IRAK4 and NF-\u03baB. Immunology: n\/a-n\/a."},{"key":"ref48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ajpath.2011.09.013","article-title":"Blockade of interleukin-6 receptor alleviates disease in mouse model of scleroderma","volume":"180","author":"S Kitaba","year":"2012","journal-title":"Am J Pathol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cytogfr.2012.04.003","article-title":"Interleukin-6, its role in fibrosing conditions","volume":"23","author":"S O\u2019Reilly","year":"2012","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3899\/jrheum.120725","article-title":"Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis","volume":"40","author":"A De Lauretis","year":"2013","journal-title":"J Rheumatol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","article-title":"Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis","volume":"71","author":"K Khan","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/rheumatology\/keq275","article-title":"The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab","volume":"49","author":"Y Shima","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"ref53","first-page":"296","article-title":"Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts","volume":"25","author":"T Kadono","year":"1998","journal-title":"J Rheumatol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2821","article-title":"Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations","volume":"11","author":"P Gourh","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archderm.1993.01680230073008","article-title":"Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders","volume":"129","author":"S Reitamo","year":"1993","journal-title":"Arch Dermatol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar2766","article-title":"Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients","volume":"11","author":"K Schmidt","year":"2009","journal-title":"Arthritis Res Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0110820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T03:40:25Z","timestamp":1566272425000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0110820"}},"subtitle":[],"editor":[{"given":"Shervin","family":"Assassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,1,28]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0110820","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,28]]}}}